After grabbing 1.13 million shares, the institutional investor is now in possession of 1.13 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 5.97% having worth around $0.22 million. Moreover, Sabby Management LLC increased its share by 0.34 million to have a control over 0.93 million shares. And Cetera Advisor Networks LLC raised its holdings to 49100.0 shares by acquiring 0.32 million shares or 1.71% of the stake.
Onconetix Inc (ONCO) concluded trading on Thursday at a closing price of $0.34, with 179.12 million shares of worth about $60.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -67.62% during that period and on Thursday, January 25 the price saw a gain of about 129.73%. Currently the company’s common shares owned by public are about 15.27M shares, out of which, 12.43M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 8 times over the past 12 months. They bought 425,440 shares in 7 of the transactions. In 1 selling transactions, insiders dumped 1,200,000 shares.
Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Fidelity Series Total Market Inde are the top 3 mutual funds which are holding stakes in Onconetix Inc Vanguard Extended Market Index Fu is currently holding 73513.0 shares of worth totaling $14556.0. The company recently came buying 0.0 shares which brought its stake up to 0.39% of the company’s outstanding shares. Fidelity Series Total Market Inde, after buying 6658.0 shares, have now control over 0.04% of the stake in the company. It holds 0.0 shares of worth $1318.0.
However, the stock later moved at a day high price of 0.4623, or with a gain of 129.73%. Stock saw a price change of 96.76% in past 5 days and over the past one month there was a price change of 78.95%. Year-to-date (YTD), ONCO shares are showing a performance of 71.72% which decreased to -73.85% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.15 but also hit the highest price of $1.95 during that period. The average intraday trading volume for Onconetix Inc shares is 482.73K. The stock is currently trading 83.81% above its 20-day simple moving average (SMA20), while that difference is up 44.99% for SMA50 and it goes to -51.13% lower than SMA200.
Armistice Capital LLC acquired 1.13 million shares of Onconetix Inc having value of about $0.22 million. Onconetix Inc (NASDAQ: ONCO) currently have 15.27M outstanding shares and institutions hold larger chunk of about 25.24% of that. Holding of mutual funds in the company is about 21.86% while other institutional holders and individual stake holders have control over 23.12% and 0.67% of the stake respectively.
The stock has a current market capitalization of $6.06M and its 3Y-monthly beta is at 3.44. It has posted earnings per share of -$1.13 in the same period. It has Quick Ratio of 0.46 while making debt-to-equity ratio of 1.26. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ONCO, volatility over the week remained 19.14% while standing at 12.88% over the month.
Analysts are in expectations that Onconetix Inc (ONCO) stock would likely to be making an EPS of -$0.21 in the current quarter, while forecast for next quarter EPS is $0 and it is -$0.85 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.21 which is -$0.21 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.2 in the same quarter a year ago.
